SPC
SSKN

Sigma Planning Corp’s Strata Skin Sciences SSKN Stock Holding History

Sigma Planning Corp’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,080
Closed -$38K – 964
2018
Q3 		$38K Buy
+1,080
New +$26.6K ﹤0.01% 945

Other funds holding SSKN

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sigma Planning Corp's SSKN Position: Q4 2018 in Review

Sigma Planning Corp sold out of Strata Skin Sciences (SSKN) in Q4 2018, closing a stake of 1,080 shares — an estimated $38K sold.

Sigma Planning Corp first reported a position in SSKN in Q3 2018 and held it in 1 quarter. The position peaked at $38K in Q3 2018. 25 funds tracked by Wall St. Rank hold SSKN as of Q4 2018.

  • Sigma Planning Corp reported no remaining Strata Skin Sciences position as of Q4 2018 after selling out during the quarter.
  • Sigma Planning Corp sold 1,080 Strata Skin Sciences shares in Q4 2018, an estimated $38K.
  • Sigma Planning Corp first reported a position in Strata Skin Sciences in Q3 2018 and held it in 1 quarter.
  • Sigma Planning Corp's Strata Skin Sciences position peaked at $38K in Q3 2018.
  • 25 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q4 2018.

Based on Sigma Planning Corp's 13F filing for Q4 2018, filed 31 Jan 2019.